» Articles » PMID: 36653413

A Novel NONO Variant That Causes Developmental Delay and Cardiac Phenotypes

Abstract

The Drosophila behavior/human splicing protein family is involved in numerous steps of gene regulation. In humans, this family consists of three proteins: SFPQ, PSPC1, and NONO. Hemizygous loss-of-function (LoF) variants in NONO cause a developmental delay with several complications (e.g., distinctive facial features, cardiac symptoms, and skeletal symptoms) in an X-linked recessive manner. Most of the reported variants have been LoF variants, and two missense variants have been reported as likely deleterious but with no functional validation. We report three individuals from two families harboring an identical missense variant that is located in the nuclear localization signal, NONO: NM_001145408.2:c.1375C > G p.(Pro459Ala). All of them were male and the variant was inherited from their asymptomatic mothers. Individual 1 was diagnosed with developmental delay and cardiac phenotypes (ventricular tachycardia and dilated cardiomyopathy), which overlapped with the features of reported individuals having NONO LoF variants. Individuals 2 and 3 were monozygotic twins. Unlike in Individual 1, developmental delay with autistic features was the only symptom found in them. A fly experiment and cell localization experiment showed that the NONO variant impaired its proper intranuclear localization, leading to mild LoF. Our findings suggest that deleterious NONO missense variants should be taken into consideration when whole-exome sequencing is performed on male individuals with developmental delay with or without cardiac symptoms.

Citing Articles

as a Model for Human Disease: Insights into Rare and Ultra-Rare Diseases.

Casas-Tinto S Insects. 2024; 15(11).

PMID: 39590469 PMC: 11594678. DOI: 10.3390/insects15110870.


An N-terminal and ankyrin repeat domain interactome of Shank3 identifies the protein complex with the splicing regulator Nono in mice.

Okuzono S, Fujii F, Setoyama D, Taira R, Shinmyo Y, Kato H Genes Cells. 2024; 29(9):746-756.

PMID: 38964745 PMC: 11447829. DOI: 10.1111/gtc.13142.


RNA binding proteins in cardiovascular development and disease.

Verma S, Kuyumcu-Martinez M Curr Top Dev Biol. 2024; 156:51-119.

PMID: 38556427 PMC: 11896630. DOI: 10.1016/bs.ctdb.2024.01.007.


X-linked intellectual developmental disorder with onset of neonatal heart failure: A case report and literature review.

Xi H, Ma L, Yin X, Yang P, Li X, Li L Mol Genet Metab Rep. 2024; 38:101054.

PMID: 38469091 PMC: 10926201. DOI: 10.1016/j.ymgmr.2024.101054.

References
1.
Knott G, Bond C, Fox A . The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold. Nucleic Acids Res. 2016; 44(9):3989-4004. PMC: 4872119. DOI: 10.1093/nar/gkw271. View

2.
Mircsof D, Langouet M, Rio M, Moutton S, Siquier-Pernet K, Bole-Feysot C . Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects. Nat Neurosci. 2015; 18(12):1731-6. PMC: 5392243. DOI: 10.1038/nn.4169. View

3.
Reinstein E, Tzur S, Cohen R, Bormans C, Behar D . Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing. Eur J Hum Genet. 2016; 24(11):1635-1638. PMC: 5110068. DOI: 10.1038/ejhg.2016.72. View

4.
Scott D, Hernandez-Garcia A, Azamian M, Jordan V, Kim B, Starkovich M . Congenital heart defects and left ventricular non-compaction in males with loss-of-function variants in NONO. J Med Genet. 2016; 54(1):47-53. DOI: 10.1136/jmedgenet-2016-104039. View

5.
Carlston C, Bleyl S, Andrews A, Meyers L, Brown S, Bayrak-Toydemir P . Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome. Am J Med Genet A. 2019; 179(5):792-796. DOI: 10.1002/ajmg.a.61091. View